The Potential of Rescheduling Cannabis to Schedule III.
Image by 7raysmarketing from Pixabay The cannabis industry was abuzz with a momentous development that could reshape the landscape of medical research, regulatory compliance, and investment. In a groundbreaking move, the Department of Justice (DOJ) and the Drug Enforcement Agency (DEA) have proposed to reschedule cannabis from Schedule I to Schedule III under the […]